• Macroeconomics
  • Deposit & Loan
    • Deposit
    • Loan
  • Equity
    • Stock Recommendation
    • Conviction Lists
    • Core Stock EPS Table
    • Core Stock Research Report
      • USA
      • JPN
    • Industry Report
  • Bond
    • New Bond Offering
    • Interest Outlook
    • Bond Recommend List
  • FX
  • Commodity
    • Commodity Outlook
    • Gold
    • Oil
  • Product Idea
  • Portfolio

Home
(4502) - Takeda Pharmaceutical Company Limited
    • Home
    • Macroeconomics
    • Deposite & Loan
      • Deposit
      • Loan
    • Equity
      • Stock Recommendation
      • Conviction Lists
      • Core Stock EPS Table
      • Core Stock Research Report
        • USA
        • JPN
      • Industry Report
    • Bond
      • New Bond Offering
      • Interest Outlook
      • Bond Recommend List
    • FX
    • Commodity
      • Commodity Outlook
      • Gold
      • Oil
    • Product Idea
    • Portfolio

    Takeda Pharmaceutical Company Limited (4502)

    • 2025.07.30

    Takeda Pharmaceutical (4502 JP) - 26/3 Q1 results: Weak US market(Buy)

    • 2025.07.22

    TAK-861: Rival drug meets primary endpoint in Phase 2 trial(Buy)

    • 2025.07.14

    Two successful phase III trials for narcolepsy type 1 drug(Buy)

    • Macroeconomics
    • Deposit & Loan
      • Deposit
      • Loan
    • Equity
      • Stock Recommendation
      • Conviction Lists
      • Core Stock EPS Table
      • Core Stock Research Report
      • USA
      • JPN
      • Industry Report
    • Bond
      • New Bond Offering
      • Interest Outlook
      • Bond Recommend List
    • FX
    • Commodity
      • Commodity Outlook
      • Gold
      • Oil
    • Product Idea
    • Portfolio
    • Start

    Decode the Economy. Master the Market.